POSC
Positron Corporation
Price Chart
Latest Quote
$1.82
+0.06 (+3.47%)
Current Price
| Previous Close | $1.76 |
| Open | $1.80 |
| Day High | $1.94 |
| Day Low | $1.80 |
| Volume | 15,309 |
Stock Information
| Shares Outstanding | 32.85M |
| Total Debt | $1.05M |
| Cash Equivalents | $1.41M |
| Revenue | $453K |
| Net Income | $-10.47M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $59.78M |
| EPS (TTM) | $-0.33 |
| Exchange | OID |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $56.83M |
| Sales | $453K |
| Income | $-10.47M |
| Book/sh | $0.01 |
| Cash/sh | $0.04 |
| Employees | 10 |
Financial Ratios
| Quick Ratio | 0.57 |
| Current Ratio | 0.87 |
| Debt/Eq | 655.27 |
Returns & Margins
| Operating Margin | -1229.69% |
Ownership
| Insider Ownership | 54.64% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 73.60 |
| P/S | 131.93 |
| P/B | 364.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.84 |
| SMA50 | $1.84 |
| SMA200 | $1.74 |
| RSI | 41.62 |
| ATR | 0.0796 |
| Shares Float | 14.90M |
| Rel Volume | 1.80 |
Performance History
| Week | +0.50% |
| Month | -0.60% |
| Quarter | -7.66% |
| 6 Months | +11.66% |
| YTD | +9.90% |
| Year | +30.94% |
| 3 Years | +40.00% |
| 5 Years | +142.99% |
| 10 Years | +5966.67% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.82 | 36,500 |
| 2026-06-17 | $1.76 | 5,700 |
| 2026-06-16 | $1.74 | 37,800 |
| 2026-06-15 | $1.79 | 5,200 |
| 2026-06-12 | $1.79 | 2,600 |
| 2026-06-11 | $1.81 | 15,400 |
| 2026-06-10 | $1.84 | 300 |
| 2026-06-09 | $1.85 | 24,000 |
| 2026-06-08 | $1.89 | 3,100 |
| 2026-06-05 | $1.86 | 16,800 |
| 2026-06-04 | $1.87 | 12,800 |
| 2026-06-03 | $1.89 | 55,300 |
| 2026-06-02 | $1.92 | 37,800 |
| 2026-06-01 | $1.92 | 26,100 |
| 2026-05-29 | $1.88 | 31,800 |
| 2026-05-28 | $1.84 | 34,600 |
| 2026-05-27 | $1.79 | 21,300 |
| 2026-05-26 | $1.85 | 3,900 |
| 2026-05-22 | $1.85 | 22,600 |
| 2026-05-21 | $1.79 | 12,900 |
| 2026-05-20 | $1.80 | 16,600 |
| 2026-05-19 | $1.83 | 5,800 |
About Positron Corporation
Positron Corporation, a medical technology company, co-develops, manufactures, and sells positron emission tomography and PET-computed tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, billing and prior-authorization assistance, physician over-read services, 24/7 clinical and technical support, priority response with after-hours service availability, equipment uptime guarantees and software upgrades, and remote system diagnostics and maintenance capabilities. The company sells its products through internal sales and marketing team. It serves healthcare providers, imaging centers, hospitals, and cardiology practices. The company was incorporated in 1983 and is headquartered in North Tonawanda, New York.
đ° Latest News
The AI gold rush is pulling private wealth into riskier, earlier bets
TechCrunch âĸ 2026-04-07T13:00:00Z
Why Arm Holdings Stock Just Popped 17%
GuruFocus.com âĸ 2026-03-25T12:19:16ZAlmost 40 new unicorns have been minted so far this year â here they are
TechCrunch âĸ 2026-03-11T18:00:00Z
Exclusive: Positron raises $230M Series B to take on Nvidiaâs AI chips
TechCrunch âĸ 2026-02-04T08:18:51Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | ||
| Reconciled Cost Of Revenue | $2,575,742 | $929,484 |
| Cost Of Revenue | $2,575,742 | $929,484 |
| Total Revenue | $461,452 | $587,500 |
| Operating Revenue | $461,452 | $587,500 |
| Expenses | ||
| Interest Expense | $125,338 | $174,079 |
| Total Expenses | $10,959,915 | $2,792,513 |
| Other Income Expense | $-15,018 | - |
| Net Non Operating Interest Income Expense | $-89,911 | $-174,079 |
| Interest Expense Non Operating | $125,338 | $174,079 |
| Operating Expense | $8,384,173 | $1,863,029 |
| General And Administrative Expense | $8,384,173 | $1,863,029 |
| Income & Earnings | ||
| Net Income From Continuing Operation Net Minority Interest | $-10,603,392 | $-2,379,092 |
| Net Interest Income | $-89,911 | $-174,079 |
| Interest Income | $35,427 | $0 |
| Normalized Income | $-10,588,374 | $-2,379,092 |
| Net Income From Continuing And Discontinued Operation | $-10,603,392 | $-2,379,092 |
| Total Operating Income As Reported | $-10,498,463 | $-2,205,013 |
| Net Income Common Stockholders | $-10,603,392 | $-2,379,092 |
| Net Income | $-10,603,392 | $-2,379,092 |
| Net Income Including Noncontrolling Interests | $-10,603,392 | $-2,379,092 |
| Net Income Continuous Operations | $-10,603,392 | $-2,379,092 |
| Pretax Income | $-10,603,392 | $-2,379,092 |
| Special Income Charges | $-15,018 | $0 |
| Interest Income Non Operating | $35,427 | $0 |
| Operating Income | $-10,498,463 | $-2,205,013 |
| Gross Profit | $-2,114,290 | $-341,984 |
| Per Share | ||
| Diluted EPS | $-0.34 | $-0.09 |
| Basic EPS | $-0.34 | $-0.09 |
| Other | ||
| Tax Effect Of Unusual Items | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-10,408,573 | $-2,166,828 |
| Total Unusual Items | $-15,018 | $0 |
| Total Unusual Items Excluding Goodwill | $-15,018 | $0 |
| Reconciled Depreciation | $54,463 | $38,185 |
| EBITDA (Bullshit earnings) | $-10,423,591 | $-2,166,828 |
| EBIT | $-10,478,054 | $-2,205,013 |
| Diluted Average Shares | $30,891,096 | $25,982,262 |
| Basic Average Shares | $30,891,096 | $25,982,262 |
| Diluted NI Availto Com Stockholders | $-10,603,392 | $-2,379,092 |
| Other Special Charges | $15,018 | - |
| Selling General And Administration | $8,384,173 | $1,863,029 |
| Other Gand A | $8,384,173 | $1,863,029 |
Fetched: 2026-04-16
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $1,443,822 | $-656,725 |
| Total Assets | $3,999,649 | $1,800,530 |
| Total Non Current Assets | $660,463 | $448,079 |
| Current Assets | $3,339,186 | $1,352,451 |
| Other Current Assets | $130,387 | $9,131 |
| Inventory | $680,000 | $1,256,862 |
| Receivables | $8,333 | $16,667 |
| Accounts Receivable | $8,333 | $16,667 |
| Cash Cash Equivalents And Short Term Investments | $2,520,466 | $69,791 |
| Cash And Cash Equivalents | $2,520,466 | $69,791 |
| Debt | ||
| Total Debt | $1,947,298 | $2,057,202 |
| Long Term Debt And Capital Lease Obligation | $153,686 | $24,302 |
| Current Debt And Capital Lease Obligation | $1,793,612 | $2,032,900 |
| Current Debt | $1,763,000 | $2,013,000 |
| Other Current Borrowings | $563,000 | $563,000 |
| Net Debt | - | $1,943,209 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $2,555,827 | $2,457,255 |
| Total Non Current Liabilities Net Minority Interest | $153,686 | $24,302 |
| Current Liabilities | $2,402,141 | $2,432,953 |
| Current Deferred Liabilities | $120,000 | $66,330 |
| Current Notes Payable | $1,200,000 | $1,450,000 |
| Payables And Accrued Expenses | $488,529 | $333,723 |
| Payables | $488,529 | $333,723 |
| Accounts Payable | $488,529 | $333,723 |
| Equity | ||
| Common Stock Equity | $1,443,822 | $-1,283,810 |
| Total Equity Gross Minority Interest | $1,443,822 | $-656,725 |
| Stockholders Equity | $1,443,822 | $-656,725 |
| Retained Earnings | $-144,937,079 | $-134,333,687 |
| Preferred Stock Equity | - | $627,085 |
| Other | ||
| Ordinary Shares Number | $31,404,258 | $27,304,258 |
| Share Issued | $31,404,258 | $27,305,008 |
| Tangible Book Value | $1,443,822 | $-1,283,810 |
| Invested Capital | $3,206,822 | $729,190 |
| Working Capital | $937,045 | $-1,080,502 |
| Capital Lease Obligations | $184,298 | $44,202 |
| Total Capitalization | $1,443,822 | $-656,725 |
| Treasury Stock | $375 | $375 |
| Additional Paid In Capital | $146,377,996 | $133,047,521 |
| Capital Stock | $3,280 | $629,816 |
| Common Stock | $3,280 | $2,731 |
| Preferred Stock | $0 | $627,085 |
| Long Term Capital Lease Obligation | $153,686 | $24,302 |
| Current Deferred Revenue | $120,000 | $66,330 |
| Current Capital Lease Obligation | $30,612 | $19,900 |
| Net PPE | $660,463 | $448,079 |
| Accumulated Depreciation | $-122,104 | $-94,727 |
| Gross PPE | $782,567 | $542,806 |
| Construction In Progress | $375,000 | $375,000 |
| Other Properties | $407,567 | $167,806 |
| Finished Goods | $680,000 | $1,256,862 |
| Treasury Shares Number | - | $750 |
| Preferred Shares Number | - | $627,085 |
Fetched: 2026-04-16
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Free Cash Flow | ||
| Free Cash Flow | $-4,799,325 | $-1,730,862 |
| Operating Activities | ||
| Operating Cash Flow | $-4,700,299 | $-1,730,862 |
| Cash Flow From Continuing Operating Activities | $-4,700,299 | $-1,730,862 |
| Investing Activities | ||
| Capital Expenditure | $-99,026 | - |
| Investing Cash Flow | $-99,026 | $0 |
| Cash Flow From Continuing Investing Activities | $-99,026 | $0 |
| Financing Activities | ||
| Repurchase Of Capital Stock | $-2,500,000 | $0 |
| Issuance Of Capital Stock | $10,000,000 | $1,400,000 |
| Financing Cash Flow | $7,250,000 | $1,700,000 |
| Cash Flow From Continuing Financing Activities | $7,250,000 | $1,700,000 |
| Net Common Stock Issuance | $7,500,000 | $1,400,000 |
| Common Stock Issuance | $10,000,000 | $1,400,000 |
| Other | ||
| Repayment Of Debt | $-350,000 | $-100,000 |
| Issuance Of Debt | $100,000 | $400,000 |
| Interest Paid Supplemental Data | $0 | $0 |
| End Cash Position | $2,520,466 | $69,791 |
| Beginning Cash Position | $69,791 | $100,653 |
| Changes In Cash | $2,450,675 | $-30,862 |
| Common Stock Payments | $-2,500,000 | $0 |
| Net Issuance Payments Of Debt | $-250,000 | $300,000 |
| Net Short Term Debt Issuance | $-250,000 | $300,000 |
| Short Term Debt Payments | $-350,000 | $-100,000 |
| Short Term Debt Issuance | $100,000 | $400,000 |
| Net PPE Purchase And Sale | $-99,026 | $0 |
| Purchase Of PPE | $-99,026 | $0 |
| Change In Working Capital | $114,225 | $45,655 |
| Change In Other Working Capital | $53,670 | $41,666 |
| Change In Other Current Liabilities | $-22,743 | $-15,006 |
| Change In Payables And Accrued Expense | $196,220 | $120,926 |
| Change In Prepaid Assets | $-121,256 | $-107,331 |
| Change In Receivables | $8,334 | $5,400 |
| Changes In Account Receivables | $8,334 | $5,400 |
| Other Non Cash Items | $174,955 | $564,390 |
| Stock Based Compensation | $4,982,588 | $0 |
| Asset Impairment Charge | $576,862 | $0 |
| Depreciation Amortization Depletion | $54,463 | $38,185 |
| Depreciation And Amortization | $54,463 | $38,185 |
| Depreciation | $54,463 | $38,185 |
| Net Income From Continuing Operations | $-10,603,392 | $-2,379,092 |
Fetched: 2026-04-16